US Supreme Court quashes Purdue opioid bankruptcy plan

Purdue Pharma’s bankruptcy plan has been rejected by the US Supreme Court, putting opioid litigation settlements in the balance. As part of the bankruptcy arrangement, members of the Sackler family who controlled the company would have been shielded from liability for any civil claims arising from the opioid epidemic. In a split decision, the court ruled this broke bankruptcy law.